Last reviewed · How we verify

NCT04271670

Effect of Warm Water Footbaths With Added Ginger or Mustard Powder on Psychosocial Parameters in Patients With an Oncological Disease

Completed NA Last updated 17 February 2020
What this trial tests

NA trial testing Ginger powder footbaths in Oncologic Disorders in 36 participants. Completed in 18 September 2017.

Timeline
15 January 2016
Primary endpoint
18 September 2017
18 September 2017

Quick facts

Lead sponsorARCIM Institute Academic Research in Complementary and Integrative Medicine
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment36
Start date15 January 2016
Primary completion18 September 2017
Estimated completion18 September 2017
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

ARCIM Institute Academic Research in Complementary and Integrative Medicine

Who can join

Adults 18 to 65, any sex, with Oncologic Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized, controlled, three-arm trial to investigate the effects of warm water footbaths with and without the addition of ginger or mustard powder on psychosocial parameters in patients with an oncological disease and in healthy controls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Oncologic Disorders

Currently open trials in the same condition.

Other ARCIM Institute Academic Research in Complementary and Integrative Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04271670.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing